PCVX Vaxcyte Inc

$32.29

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About Vaxcyte Inc

Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. The company is headquartered in Foster City, California.

Website: https://vaxcyte.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1649094
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, US
Valuation
Market Cap
$3.95B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
1.19
Performance
EPS
$-3.80
Dividend Yield
Profit Margin
0.00%
ROE
-20.40%
Technicals
50D MA
$64.15
200D MA
$86.23
52W High
$121.06
52W Low
$27.66
Fundamentals
Shares Outstanding
129M
Target Price
$132.00
Beta
1.26

PCVX EPS Estimates vs Actual

Estimated
Actual

PCVX News & Sentiment

Aug 07, 2025 • Benzinga NEUTRAL
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - ADMA Biologics ( NASDAQ:ADMA ) , Airbnb ( NASDAQ:ABNB )
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Thursday. Shares of Redwire Corporation RDW fell sharply in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY25 sales guidance.
Aug 07, 2025 • Motley Fool SOMEWHAT-BULLISH
Vaxcyte ( PCVX ) Q2 Loss Widens 11%
Vaxcyte ( NASDAQ:PCVX ) , a biotechnology company specializing in next-generation vaccines, reported its second quarter 2025 results on August 6, 2025. The company reported a GAAP net loss per share of $ ( 1.22 ) , missing the consensus estimate of $ ( 1.16 ) .
May 01, 2025 • Benzinga SOMEWHAT-BULLISH
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - Vaxcyte ( NASDAQ:PCVX )
SAN CARLOS, Calif., May 01, 2025 ( GLOBE NEWSWIRE ) -- Vaxcyte, Inc.
May 01, 2025 • Business Insider SOMEWHAT-BULLISH
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
SAN CARLOS, Calif., May 01, 2025 ( GLOBE NEWSWIRE ) -- Vaxcyte, Inc. ( Nasdaq: PCVX ) , a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed Dr. Olivier Brandicourt, a veteran ...
May 01, 2025 • GlobeNewswire NEUTRAL
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
SAN CARLOS, Calif., May 01, 2025 ( GLOBE NEWSWIRE ) -- Vaxcyte, Inc. ( Nasdaq: PCVX ) , a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed Dr. Olivier Brandicourt, a veteran ...
Apr 23, 2025 • CNBC NEUTRAL
Corporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses
Corporations like Target, McDonald's and Delta donated to Trump's inaugural committee after skipping the last two cycles. Now he has roiled their businesses.
Sentiment Snapshot

Average Sentiment Score:

0.126
50 articles with scored sentiment

Overall Sentiment:

Neutral

PCVX Reported Earnings

Feb 25, 2025
Dec 31, 2024 (Post market)
-0.03 Surprise
  • Reported EPS: $-1.02
  • Estimate: $-0.99
  • Whisper:
  • Surprise %: -2.6%
Nov 04, 2024
Sep 30, 2024 (Pre market)
0.3 Surprise
  • Reported EPS: $-0.83
  • Estimate: $-1.13
  • Whisper:
  • Surprise %: 26.6%
Aug 06, 2024
Jun 30, 2024 (Post market)
-0.12 Surprise
  • Reported EPS: $-1.10
  • Estimate: $-0.98
  • Whisper:
  • Surprise %: -12.2%
May 08, 2024
Mar 31, 2024 (Post market)
0.32 Surprise
  • Reported EPS: $-0.85
  • Estimate: $-1.17
  • Whisper:
  • Surprise %: 27.4%
Feb 27, 2024
Dec 31, 2023 (Post market)
-0.75 Surprise
  • Reported EPS: $-1.82
  • Estimate: $-1.07
  • Whisper:
  • Surprise %: -70.1%
Nov 06, 2023
Sep 30, 2023 (Post market)
-0.07 Surprise
  • Reported EPS: $-0.91
  • Estimate: $-0.84
  • Whisper:
  • Surprise %: -8.3%
Aug 08, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $-0.70
  • Estimate: $-0.74
  • Whisper:
  • Surprise %: 5.4%
May 08, 2023
Mar 31, 2023 (Post market)
0.13 Surprise
  • Reported EPS: $-0.70
  • Estimate: $-0.83
  • Whisper:
  • Surprise %: 15.7%
Feb 27, 2023
Dec 31, 2022 (Post market)
-0.09 Surprise
  • Reported EPS: $-1.02
  • Estimate: $-0.93
  • Whisper:
  • Surprise %: -9.7%

Financials